Barriers to early diagnosis of chronic kidney disease and use of sodium‐glucose cotransporter‐2 inhibitors for renal protection: A comprehensive review and call to action

Documenti analoghi

• Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia
  di: Yuri Sakai Ishizaki, et al.
  Pubblicazione: (2024)
• Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
  di: Afif Nakhleh, et al.
  Pubblicazione: (2024)
• Sodium–glucose cotransporter 2 inhibitors for hypertension in cardiovascular–kidney–metabolic syndrome
  di: Chunxiang Xu, et al.
  Pubblicazione: (2025)
• Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan
  di: Keiko Maruyama‐Sakurai, et al.
  Pubblicazione: (2024)
• The SGLT family—sodium‐glucose transporters with roles beyond glucose and the kidney
  di: David Mathew, et al.
  Pubblicazione: (2024)